Get startedLog in
    Picture of Cue Biopharma logo

    CUE — Cue Biopharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Brief: Boehringer Ingelheim, Cue Biopharma Partner To Develop Autoimmune And Inflammatory Disease Treatments

    Picture of Cue Biopharma logoCue Biopharma
    14/04/2025 22:34
    April 14 (Reuters) - Cue Biopharma Inc CUE.O:

BOEHRINGER INGELHEIM AND CUE BIOPHARMA PARTNER TO DEVELOP TREATMENT FOR AUTOIMMUNE AND INFLAMMATORY DISEASES

CUE BIOPHARMA INC: UNDER COLLABORATION, CO TO RECEIVE  UP-FRONT PAYMENT OF $12 MILLION AS WELL AS RESEARCH SUPPORT PAYMENTS

CUE BIOPHARMA INC: CO IS ALSO ELIGIBLE TO EARN UP TO  ABOUT $345 MILLION IN MILESTONE-BASED PAYMENTS

Source text: ID:nGNX8hQfzZ

Further company coverage: CUE.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Cue Biopharma

    See all news